CAS: 28910-99-8

Applications Nitrazolam is a designer benzodiazepine substance which displays psychoactive activity. May be used in the self-treatment of anxiety or mental disorders. References Moosmann, B. et al.: J. Mass Spec. 51, 1080 (2016)

Nitrazolam is a benzodiazepine compound that may exhibit central nervous system depressant properties similar to traditional benzodiazepine drugs by acting on the GABA receptors (GABA receptor). These effects include sedation, hypnosis, anxiolytic, and anticonvulsant activities.

Nitrazolam is a drug that falls into the category of benzodiazepines. It binds to metabotropic glutamate receptors and modulates their activity. Nitrazolam has been shown to be effective in treating infectious diseases, such as HIV, and cancer. It has also been shown to have anti-inflammatory properties and may be used for the treatment of inflammatory diseases such as depression. The phosphate group is essential for its pharmacological effects. Nitrazolam is metabolized by hydrolysis of the ester linkage with either acid or alkaline hydrolysis, yielding clonazolam, which is a similar compound with different properties.